Home Stock Market ClearSign Applied sciences Company (CLIR) Q1 2023 Earnings Name Transcript

ClearSign Applied sciences Company (CLIR) Q1 2023 Earnings Name Transcript

ClearSign Applied sciences Company (CLIR) Q1 2023 Earnings Name Transcript


ClearSign Applied sciences Company (NASDAQ:CLIR) Q1 2023 Earnings Convention Name Could 18, 2023 5:00 PM ET

Firm Individuals

Matthew Selinger – Investor Relations

Jim Deller – President, Chief Govt Officer

Brent Hinds – Vice President, Finance, Controller

Convention Name Individuals

Amit Dayal – H.C. Wainwright

Robert Kecseg – Las Colinas


Good day, and welcome to the ClearSign Applied sciences’ First Quarter 2023 Convention Name. [Operator Instructions] Please word this occasion is being recorded. I’d now like to show the convention over to Matthew Selinger of Agency IR Group. Please go forward.

Matthew Selinger

Good afternoon, and thanks, operator. Welcome, everybody, to the ClearSign Applied sciences Company first quarter 2023 outcomes convention name. Throughout this convention name, the corporate will make forward-looking statements. Any assertion that isn’t an announcement of historic truth is a forward-looking assertion. This consists of remarks concerning the firm’s projections, expectations, plans, beliefs and prospects. These statements are based mostly on judgments and evaluation as of the date of this convention name and are topic to quite a few vital dangers and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements. The dangers and uncertainties related to the forward-looking statements made on this convention name embrace, however aren’t restricted to, whether or not discipline testing and gross sales of ClearSign merchandise shall be efficiently accomplished, whether or not ClearSign shall be profitable in increasing the marketplace for its merchandise and different dangers which might be described with ClearSign’s public periodic filings with the SEC, together with the dialogue within the Danger Components part of the 2022 annual report on Type 10-Okay and the quarterly report on Type 10-Q for the quarterly interval ended March 31, 2023. So besides as required by legislation, ClearSign assumes no duty to replace these forward-looking statements to replicate future occasions or precise outcomes and doesn’t intend to take action.


Source link


Please enter your comment!
Please enter your name here